SG11202102204PA - Process of making calcium alpha-ketoglutarate - Google Patents

Process of making calcium alpha-ketoglutarate

Info

Publication number
SG11202102204PA
SG11202102204PA SG11202102204PA SG11202102204PA SG11202102204PA SG 11202102204P A SG11202102204P A SG 11202102204PA SG 11202102204P A SG11202102204P A SG 11202102204PA SG 11202102204P A SG11202102204P A SG 11202102204PA SG 11202102204P A SG11202102204P A SG 11202102204PA
Authority
SG
Singapore
Prior art keywords
ketoglutarate
making calcium
calcium alpha
alpha
making
Prior art date
Application number
SG11202102204PA
Other languages
English (en)
Inventor
David Eugene Pereira
Keshav Deo
Original Assignee
Ponce De Leon Health Designated Activity Company
David Eugene Pereira
Keshav Deo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ponce De Leon Health Designated Activity Company, David Eugene Pereira, Keshav Deo filed Critical Ponce De Leon Health Designated Activity Company
Publication of SG11202102204PA publication Critical patent/SG11202102204PA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C07C51/418—Preparation of metal complexes containing carboxylic acid moieties
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/347—Saturated compounds containing more than one carboxyl group containing keto groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SG11202102204PA 2018-09-25 2019-09-23 Process of making calcium alpha-ketoglutarate SG11202102204PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862736320P 2018-09-25 2018-09-25
PCT/US2019/052498 WO2020068705A1 (en) 2018-09-25 2019-09-23 Process of making calcium alpha-ketoglutarate

Publications (1)

Publication Number Publication Date
SG11202102204PA true SG11202102204PA (en) 2021-04-29

Family

ID=69952136

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202102204PA SG11202102204PA (en) 2018-09-25 2019-09-23 Process of making calcium alpha-ketoglutarate

Country Status (17)

Country Link
US (1) US11802103B2 (ja)
EP (1) EP3856166A4 (ja)
JP (1) JP7499259B2 (ja)
KR (1) KR20210065120A (ja)
CN (1) CN112955139A (ja)
AU (1) AU2019350699B2 (ja)
BR (1) BR112021005668A2 (ja)
CA (1) CA3112205A1 (ja)
CL (1) CL2021000728A1 (ja)
CO (1) CO2021004529A2 (ja)
IL (1) IL281761A (ja)
MX (1) MX2021003482A (ja)
PE (1) PE20211816A1 (ja)
PH (1) PH12021550403A1 (ja)
SG (1) SG11202102204PA (ja)
TW (1) TW202024013A (ja)
WO (1) WO2020068705A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7499259B2 (ja) 2018-09-25 2024-06-13 ポンス デ レオン ヘルス デジグネイテッド アクティビティ カンパニー αケトグルタル酸カルシウムを製造するためのプロセス
CN112941116B (zh) * 2021-01-04 2022-12-02 上海朴颐化学科技有限公司 一种酶法制备α-酮戊二酸钙的方法

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2776926A (en) 1955-08-04 1957-01-08 Eugene S Sharpe Preparation of alpha-ketoglutaric acid by serratia marcescens
US2917528A (en) 1956-08-24 1959-12-15 Victor Chemical Works Alkanolaminealkanephosphonic acids and salts thereof
US2841616A (en) * 1956-10-30 1958-07-01 Campbell Soup Co Process for the recovery of alpha-ketoglutaric acid
US3875304A (en) 1970-04-24 1975-04-01 Schlitz Brewing Co J Livestock feed composition and method of preparing the same
US4045585A (en) 1976-05-19 1977-08-30 Decel Corporation Flavored animal food compositions
DE3151196A1 (de) * 1981-12-23 1983-06-30 Kurt Heinz Prof. Dr. 7800 Freiburg Bauer Verfahren zur herstellung von gut loeslichen 5-aminosalicylsaeure-arzneimittelzubereitungen
US6451341B1 (en) 1990-02-05 2002-09-17 Thomas J. Slaga Time release formulation of vitamins, minerals and other beneficial supplements
US5646187A (en) 1992-05-20 1997-07-08 Ab Erik Vinnars Use of alpha-ketoglutarate
US6306430B1 (en) 1998-04-16 2001-10-23 The Iams Company Process for decreasing adiposity using vitamin a as a dietary supplement
US6905707B2 (en) 1998-05-28 2005-06-14 Medical Research Institute Controlled release arginine alpha ketoglutarate
CO5140079A1 (es) 1998-10-14 2002-03-22 Novartis Ag Composicion farmaceutica de liberacion sostenida y metodo para liberar un agente farmaceuticamente activo de liberacion sostenida y metodo para liberar un agente far- maceuticamente activo
US6649654B1 (en) 1999-11-23 2003-11-18 The Regents Of The University Of California Methods for identifying and using IKK inhibitors
AU2895502A (en) 2000-12-20 2002-07-01 Alcon Universal Ltd Solution for removing cataracts via liquefracture
AU2004237437B2 (en) * 2003-05-07 2011-01-20 Osteologix A/S Controlled release composition containing a strontium salt
KR20110124317A (ko) * 2004-05-06 2011-11-16 오스테올로지스 에이에스 금속 유기 염의 제조를 위한 고 수율 및 고속 합성 방법
PL368572A1 (en) 2004-06-17 2005-12-27 Sgp & Sons Ab Pharmaceutical compound for prevention and therapy of increased level of cholesterol, ldl and triglycerides as well as application of the pharmaceutical compound as an agent acting against atherosclerosis and used in circulatory system affections
CA2574597A1 (en) 2004-08-09 2006-02-16 Cancer Research Technology Limited Alpha-ketoglutarates and their use as therapeutic agents
ES2510690T3 (es) 2004-12-17 2014-10-21 Alan B. Cash Método para extender la esperanza de vida y retrasar la aparición de enfermedad relacionada con la edad
US20060234250A1 (en) 2005-04-15 2006-10-19 Powers Ralph W Iii Methods of screening and compositions for life span modulators
US20070135376A1 (en) 2005-06-20 2007-06-14 Accera, Inc. Method to reduce oxidative damage and improve mitochondrial efficiency
WO2007053943A1 (en) 2005-11-08 2007-05-18 Multi Formulations Ltd. The use of compositions comprising ketoacids and amino acids for increasing muscle mass and muscle performance
US8367121B2 (en) 2005-11-23 2013-02-05 Florida A & M University Nutraceutical agent for attenuating the neurodegenerative process associated with Parkinson's disease
PL379512A1 (pl) 2006-04-21 2007-10-29 Sgp & Sons Ab Nowe metody i ich zastosowanie
PL226695B1 (pl) 2006-07-03 2017-08-31 Danuta Kruszewska Środek do zastosowania w zapobieganiu i/lub hamowaniu kolonizacji Helicobacter pylori, zastosowanie soli kwasu alfa‑ketoglutarowego z metalami alkalicznymi i ziem alkalicznych do wytwarzania środka leczniczego oraz dodatku do żywności do zapobiegania i/lub hamowania kolonizacji Helicobacter pylori
WO2008115783A1 (en) 2007-03-19 2008-09-25 Metaproteomics, Llc Methods and compositions for promoting bone and joint health
EP2173336B1 (en) 2007-07-02 2016-03-30 Protista Biotechnology AB Alpha-ketoglutaric acid for use in the treatment of hypertension or pulmonary hypertension
EP2033623A1 (en) 2007-09-07 2009-03-11 Cutech S.R.L. Compositions comprising ornithine ketoglutarate (OKG)
JP5406643B2 (ja) 2008-09-22 2014-02-05 日本合成化学工業株式会社 α−オキソカルボン酸の金属塩の製造方法
CN101759553A (zh) 2008-11-21 2010-06-30 扬子江药业集团北京海燕药业有限公司 α-酮酸钙的制备方法
DE102009016119A1 (de) 2009-04-03 2010-10-14 Evonik Degussa Gmbh Nahrungsergänzungsmittel enthaltend alpha-Ketosäuren zur Unterstützung der Diabetestherapie
ES2685947T3 (es) 2009-04-10 2018-10-15 Haiyan Qi Agentes antienvejecimiento
MX2011011947A (es) 2009-05-11 2012-01-30 Berg Biosystems Llc Metodos para el diagnostico de trastornos metabolicos usando intercambiadores epimetabolicos, moleculas intracelulares multidimensionales, o influyentes ambientales.
EP2434908A2 (en) 2009-05-28 2012-04-04 The IAMS Company Pet food in the form of a coated kibble
US9050277B2 (en) 2009-06-12 2015-06-09 Generex Pharmaceuticals, Inc. Combined Geum japonicum and Centella asiatica extracts for the therapeutic treatment of heart failure
ES2600909T3 (es) 2009-06-30 2017-02-13 Derman Biomedicine Co. Ltd. Composiciones que contienen berberina o análogos de la misma para tratar rosácea o trastornos de la piel relacionados con enrojecimiento de la cara
WO2011060305A1 (en) 2009-11-12 2011-05-19 Nox Technologies, Inc. Potato skin compositions that lower cytosolic nadh level to mimic calorie restriction
WO2012114204A2 (en) 2011-02-15 2012-08-30 Ecole Polytechnique Federale De Lausanne (Epfl) Epfl-Tto Methods of treating mitochondrial dysfunction
AU2012244750A1 (en) 2011-04-18 2013-10-17 Nestec S.A. Nutritional compositions having alpha-HICA and eicosapentaenoic acid
WO2012174537A2 (en) 2011-06-16 2012-12-20 President And Fellows Of Harvard College Small molecule screening for mouse satellite cell proliferation
CN102586347B (zh) * 2012-03-06 2014-04-09 江南大学 一种两阶段pH控制高产a-酮戊二酸的方法
US9532997B2 (en) 2012-04-03 2017-01-03 Whitehead Institute For Biomedical Research Compositions and methods for promoting intestinal stem cell function
ITBO20120226A1 (it) 2012-04-24 2013-10-25 Alfa Wassermann Spa Composizioni comprendenti ornitina alfa-chetoglutarato, processi per il loro ottenimento e il loro uso.
JP6029058B2 (ja) 2012-09-14 2016-11-24 国立研究開発法人農業・食品産業技術総合研究機構 シュウ酸カルシウムを含む氷核活性剤
KR102198633B1 (ko) 2012-09-19 2021-01-05 그레스포 에이비 뇌기능 향상용 조성물
CN102976927A (zh) * 2012-12-26 2013-03-20 天津天成制药有限公司 α-酮戊二酸钙的制备方法
WO2014103475A1 (ja) 2012-12-27 2014-07-03 株式会社林原 アンチエイジング用皮膚外用組成物及びその製造方法
US20150328176A1 (en) 2013-01-25 2015-11-19 Winning The Fight Inc. Composition for treatment of neurodegenerative disease
US9511057B2 (en) 2013-03-15 2016-12-06 The Board Of Trustees Of The Leland Stanford Junior University Methods for treating denervation-induced muscle atrophy
NZ711433A (en) 2013-03-19 2017-03-31 Univ South Florida Compositions and methods for producing elevated and sustained ketosis
US20160263092A1 (en) 2013-12-19 2016-09-15 Twi Biotechnology, Inc. Therapeutic uses of berberine formulations
WO2015123229A1 (en) 2014-02-12 2015-08-20 The Regents Of The University Of California Compositions and methods for treating aging and age-related diseases and symptoms
US10258639B2 (en) 2014-05-06 2019-04-16 Research Development Foundation Methods for treating insulin resistance and for sensitizing patients to GLP1 agonist therapy
CA2953387C (en) 2014-06-30 2023-11-28 The Regents Of The University Of California Ketobutyrate compounds and compositions for treating age-related symptoms and diseases
BR112017001623B1 (pt) 2014-07-29 2022-11-29 Shenzhen Hightide Biopharmaceutical, Ltd Sal de adição ácido-base em uma forma substancialmente pura, composição farmacêutica compreendendo uma quantidade do referido sal e seus usos
WO2016019224A1 (en) 2014-07-31 2016-02-04 Indiana University Research And Technology Corporation Antithetical regulation of endothelial ace and ace2 by brg1-foxm1 complex underlies pathological cardiac hypertrophy
CN104529755B (zh) * 2014-12-29 2016-01-06 精晶药业股份有限公司 一种从转化液中分离α-酮戊二酸的方法
JP2018517666A (ja) 2015-04-06 2018-07-05 シンセン ハイタイド バイオファーマシューティカル リミテッド ウルソデオキシコール酸、ベルベリンまたはｌ−カルニチンのコンジュゲート化合物、ならびにその組成物および方法
ES2932801T3 (es) 2015-06-10 2023-01-26 Elysium Health Inc Composiciones de ribósido de nicotinamida y pterostilbeno y métodos para el tratamiento de trastornos de la piel
US20180193458A1 (en) 2015-07-08 2018-07-12 Unity Biotechnology, Inc. Compositions and methods for treating senescence-associated diseases and disorders
WO2018064468A1 (en) 2016-09-30 2018-04-05 The Regents Of The University Of California Alpha-ketobutyrate, alpha-ketoglutarate, and 2-hydroxybutyrate for stimulating hair growth
PL231635B1 (pl) * 2017-01-03 2019-03-29 Politechnika Poznanska Sposób produkcji kwasu alfa-ketoglutarowego (AKG) z jednoskładnikowych roztworów wodnych
MX2017004010A (es) 2017-03-27 2018-02-09 Antonio Hernandez Miramontes Jorge Mezcla de oxalacetato, alfacetoglutarato, ácido tartánico y sales de lactato de calcio y sodio, para tratar pacientes con insuficiencia renal crónica.
BR112019022455A2 (pt) 2017-04-25 2020-05-12 Buck Institute For Research On Aging Formulações para prolongar o tempo de vida e de saúde
WO2019038655A1 (en) 2017-08-21 2019-02-28 The Regents Of The University Of California COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES
JP7499259B2 (ja) 2018-09-25 2024-06-13 ポンス デ レオン ヘルス デジグネイテッド アクティビティ カンパニー αケトグルタル酸カルシウムを製造するためのプロセス
WO2020086733A1 (en) 2018-10-24 2020-04-30 Ponce De Leon Health Designated Activity Company Nicotinamide riboside compositions for healthspan extension
CN114126599A (zh) 2019-06-10 2022-03-01 巴克老龄化研究所 改变衰老相关分泌表型的方法和组合物
JP2022537685A (ja) * 2019-06-10 2022-08-29 ポンス デ レオン ヘルス デジクネイテッド アクティビティ カンパニー アルファ－ケトグルタル酸塩の持続放出組成物
WO2022006500A1 (en) 2020-07-02 2022-01-06 Ponce De Leon Health Designated Activity Company Compositions and methods for treating crp-mediated diseases
CN115974679A (zh) * 2022-12-20 2023-04-18 绍兴市精益生物化工有限公司 α-酮戊二酸钙盐制备方法

Also Published As

Publication number Publication date
US11802103B2 (en) 2023-10-31
BR112021005668A2 (pt) 2021-06-22
US20210371368A1 (en) 2021-12-02
PE20211816A1 (es) 2021-09-14
CL2021000728A1 (es) 2021-10-22
IL281761A (en) 2021-05-31
MX2021003482A (es) 2021-06-18
JP7499259B2 (ja) 2024-06-13
KR20210065120A (ko) 2021-06-03
EP3856166A4 (en) 2022-06-22
WO2020068705A1 (en) 2020-04-02
PH12021550403A1 (en) 2021-10-04
CO2021004529A2 (es) 2021-04-30
TW202024013A (zh) 2020-07-01
JP2022502489A (ja) 2022-01-11
CA3112205A1 (en) 2020-04-02
AU2019350699B2 (en) 2024-05-23
EP3856166A1 (en) 2021-08-04
CN112955139A (zh) 2021-06-11
AU2019350699A1 (en) 2021-04-08

Similar Documents

Publication Publication Date Title
SI3630738T1 (sl) Postopek za ustvarjanje ozanimoda
ZA202004497B (en) Process of making somatostatin modulators
ZA202105072B (en) Production line of ca abrasive
GB201804594D0 (en) Bonegraft substituteand method of manufacture
GB201806072D0 (en) Methods of manufacture
PT3487812T (pt) Produção de carbonato de cálcio amorfo
IL281761A (en) Process for preparing calcium alpha-ketoglutarate
GB201802839D0 (en) Method of manufacture
PL3755681T3 (pl) Sposób wytwarzania 4-boronofenyloalaniny
GB201805904D0 (en) Methods of Manufacture
PL3856700T3 (pl) Sposób wytwarzania kształtki węglowo-ceramicznej
GB201814291D0 (en) Process for the production of gallium radionculides
NO20170008A1 (en) A process for treatment of fly ash
IL281378A (en) Improved production method for Isomalt
ZA202101670B (en) Process for the production of syngas
HUP1800125A2 (en) Process for production of iloprost
HUE057578T2 (hu) Eljárás módosított keményítõféleségek gyártása során képzõdõ szennyvíz feldolgozására
PT3759082T (pt) Processo para a síntese de 6-clorometiluracilo
PL3609842T3 (pl) Sposób wytwarzania wytrąconego węglanu wapnia (pcc)
ZA201801284B (en) Production of form coke
IL256062B (en) Process for treating of threads
EP3974411C0 (en) PROCESS FOR PREPARING DIAZOMETHANE
HUP1800088A2 (hu) Eljárás keményítõ antigradálására
HUE037485T2 (hu) Javított eljárás kicsapott kalciumkarbonát elõállítására
HUE063678T2 (hu) Eljárás peroxiészterek elõállítására